The authors reply

New England Journal of Medicine

Volumn 375, Issue 8, 2016, Pages 802-803

  Kudenchuk, Peter J ^a   Daya, Mohamud ^b   Dorian, Paul ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; LIDOCAINE; PLACEBO; ANTIARRHYTHMIC AGENT;

BRADYCARDIA; COHORT ANALYSIS; DISEASE DURATION; ELECTRIC ACTIVITY; EMERGENCY HEALTH SERVICE; HEART VENTRICLE FIBRILLATION; HUMAN; LETTER; OUT OF HOSPITAL CARDIAC ARREST; PRIORITY JOURNAL; PULSELESS VENTRICULAR TACHYCARDIA; SHOCK REFRACTORY VENTRICULAR FIBRILLATION; SURVIVAL RATE; HEART ARREST; RESUSCITATION; TREATMENT OUTCOME;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; EMERGENCY MEDICAL SERVICES; HEART ARREST; HUMANS; LIDOCAINE; OUT-OF-HOSPITAL CARDIAC ARREST; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84983552154     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1608041     Document Type: Letter

References (4)

1. Kudenchuk PJ, Brown SP, Daya M, et al. Resuscitation Outcomes Consortium - Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. Am Heart J 2014;167(5):653-9.e4.
2. Chow MS, Ronfeld RA, Ruffett D, Fieldman A. Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation. Am Heart J 1981;102:799-801.
3. Hendrie J, O'Callaghan CJ. Lidocaine pharmacokinetics after cardiac arrest and external cardiopulmonary resuscitation. Am J Cardiol 1996;78:1322-3.
4. Goodman SN. Statistics: aligning statistical and scientific reasoning. Science 2016;352:1180-1.